• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.

作者信息

Kingra G S, Comis R, Olson K B, Horton J

出版信息

Cancer Chemother Rep. 1971 Jun;55(3):281-3.

PMID:5115849
Abstract
摘要

相似文献

1
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
Cancer Chemother Rep. 1971 Jun;55(3):281-3.
2
Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.
3
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。
Cancer Chemother Rep. 1970 Apr;54(2):119-24.
4
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。
Cancer Chemother Rep. 1970 Dec;54(6):471-3.
5
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.
6
Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）治疗播散性黑色素瘤患者的研究。
Cancer Chemother Rep. 1973 Feb;57(1):83-4.
7
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.阿霉素与二甲基三氮烯咪唑甲酰胺联合用于肉瘤的化疗。
Cancer. 1972 Dec;30(6):1632-8. doi: 10.1002/1097-0142(197212)30:6<1632::aid-cncr2820300632>3.0.co;2-s.
8
Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）静脉给药治疗乌干达恶性黑色素瘤的临床试验。
Cancer Chemother Rep. 1971 Apr;55(2):143-9.
9
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Cancer Chemother Rep. 1972 Aug;56(4):523-6.
10
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].[采用5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（达卡巴嗪；NSC-45388）、1,3-双(2-氯乙基)-1-亚硝基脲（卡莫司汀，NSC-409962）和长春新碱（NSC-67574）对黑色素瘤转移期进行多药化疗]
Tumori. 1973 May-Jun;59(3):239-48. doi: 10.1177/030089167305900305.

引用本文的文献

1
Mechanisms of hepatotoxicity caused by dacarbazine in rats.达卡巴嗪对大鼠肝毒性的作用机制
J Cancer Res Clin Oncol. 1993;119(8):475-81. doi: 10.1007/BF01215928.